- classification of variations (type I, type II)
- preparation of necessary documnets (depending on variation)
- expert reports for variations
- revision of information materials (if necessary)
- finding market niche for new product
- preparation of indications acc to binding regulations
- anticipation of decision of authorities
- preparation of new DS based on single or multiple constituents
- preparation and evaluation of information materials
- preparation and evaluation of advertisements
- generic medicinal product (bioequivalence based)
- generic medicinal product, according to „well established use” procedure
- choice of the strategy
- evaluation of chances for success
- preparation of health technology assessment (HTA)
- appraisal of HTA
- analysis of safety
- reimbursement of bio-similars
Our experience:
- registration of 81 generics: Poland, 20 products; UK, 42 products; and German, 21 products
- we have successfully applied for 400 variations during our 4-years long activity
- we have published two papers regarding pharmacoeconomics
© 2009 ClinicPharma, ul. Modrzewiowa 5, 05-820 Piastów, Poland, tel.: +48 22 723 28 68, e-mail: info@clinicpharma.com
Webdesign:
Unistyle.pl
Unistyle.pl
























